Adam Torkildson – Lifestyle
Author:
Kailera Therapeutics, Inc.
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
May 13, 2026
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 20, 2026
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 16, 2026